CAR T-cell design dependent remodeling of the brain tumor immune microenvironment identify macrophages as key players that inhibit or promote anti-tumor activity 【IF: 0】Res Sq. 2023 Jun 6;rs.3.rs-2972427 BLZ945 (Sotuletinib) purchased from AbMole
Patent. WO2023147868A1 【IF: 0】Patent. WO2023147868A1 2023 Aug 10 Imatinib purchased from AbMole
Patent. CN115154451B 【IF: 0】Patent. CN115154451B 2023 Oct 13 NMDA purchased from AbMole
Patent. TW202327591A 【IF: 0】Patent. TW202327591A 2023 Jul 16 NADPH tetrasodium salt purchased from AbMole
Patent. CN117050934A 【IF: 0】Patent. CN117050934A 2023 Nov 14 Y-27632 dihydrochloride purchased from AbMole
Patent. CN115381817B 【IF: 0】Patent. CN115381817B 2023 Sep 05 BLZ945 (Sotuletinib) purchased from AbMole
Patent. KR20230169838A 【IF: 0】Patent. KR20230169838A 2023 Dec 18 Y-27632 dihydrochloride purchased from AbMole
Patent. CN116687920A 【IF: 0】Patent. CN116687920A 2023 Sep 05 Cytarabine purchased from AbMole
Patent. CN114480250B 【IF: 0】Patent. CN114480250B 2023 Sep 08 Y-27632 dihydrochloride purchased from AbMole
Patent. CN116987669A 【IF: 0】Patent. CN116987669A 2023 Nov 03 CHIR-99021 purchased from AbMole
Breast cancer intrinsic YTHDF1 forms “cold” tumor and inhibits CD8+ T cells infiltration and function 【IF: 0】Research Square. 2023 May 5 Phorbol 12-myristate 13-acetate purchased from AbMole
Patent. CN112852714B 【IF: 0】Patent. CN112852714B 2023 Jul 21 Y-27632 dihydrochloride purchased from AbMole
Products are for research use only. Not for human use. We do not sell to patients.© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
